To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the measurement of the wheal and flare from histamine skin prick testing. This is an open label, two-week, post-marketing study conducted on histamine responsive patients.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
30
Bepreve (bepotastine besilate ophthalmic solution 1.5%) one drop in each eye twice daily
Refresh Tears one drop to each eye twice daily for 7 days after the conclusion of Bepreve treatment
North Texas Institute for Clinical Trials
Fort Worth, Texas, United States
measurement of Wheal and Flare response from histamine skin-prick testing
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.